Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic...

  • Main
  • 2019 / 9
  • Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic...

Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Wei, Xiaoxia, Sun, Hong, Zhuang, Jie, Weng, Xiuhua, Zheng, Bin, Lin, Qiwang, Zhang, Guifeng, Cai, Jiaqin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-019-00842-0
Date:
September, 2019
File:
PDF, 1.47 MB
2019
Conversion to is in progress
Conversion to is failed